Worldwide Hormone Refractory Breast Cancer Market 2017- Strategy Resources, Manufacturers, Supply and Forecasts 2023
Latest industry research report on Hormone Refractory Breast Cancer Market. Breast cancer is one of the most common type of malignant cancers, which is prevalent in women above 40 years. As per World Health Organization (WHO) estimates, breast cancer accounted for around 521,000 deaths globally in 2012. Generally, hormone therapies are used for treating breast cancer, which subsequently leads to resistance after continuous use of hormone therapy.
View full press release